--2024/Q4-- / 4.129B--
Nov 6, 20242024/Q3-- / 4.125B--
Jul 31, 20242024/Q24.164B / 4.045B--
May 8, 20242024/Q13.819B / 3.740B--
Jan 31, 20242023/Q44.457B / 4.010B--
US Stock MarketDetailed Quotes
TEVA Teva Pharmaceutical Industries
- 18.440
- -0.150-0.81%
Close Oct 31 16:00 ET
- 18.520
- +0.080+0.43%
Post 17:52 ET
20.89BMarket Cap-47282P/E (TTM)
18.470High18.230Low6.88MVolume18.250Open18.590Pre Close126.62MTurnover0.61%Turnover RatioLossP/E (Static)1.13BShares19.08052wk High3.29P/B20.77BFloat Cap8.54552wk Low--Dividend TTM1.13BShs Float68.007Historical High--Div YieldTTM1.29%Amplitude3.107Historical Low18.400Avg Price1Lot Size
Teva Pharmaceutical Industries Key Stats
Teva Pharmaceutical Industries Q3 2024 Estimates Date
Currency：USDNov 6, 2024
| Estimate | YoY | |
| Revenue | 4.13B | +7.14% |
| EPS | -<0.01 | -103.57% |
Analyst Rating
Oct 31, 2024
Teva Pharmaceutical Industries Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Teva Pharmaceutical Industries Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
